Literature DB >> 2440219

The management of hyperthyroidism due to Graves' disease in Europe in 1986. Results of an international survey.

D Glinoer, D Hesch, R Lagasse, P Laurberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2440219

Source DB:  PubMed          Journal:  Acta Endocrinol Suppl (Copenh)        ISSN： 0300-9750


× No keyword cloud information.
  20 in total

1.  Trends in diagnostic and therapeutic criteria in Graves' disease in the last 10 years.

Authors:  F Escobar-Jiménez; M L Férnandez-Soto; V Luna-López; M Quesada-Charneco; D Glinoer
Journal:  Postgrad Med J       Date:  2000-06       Impact factor: 2.401

2.  The management of hyperthyroidism due to Graves' disease in the former USSR in 1991: results of a survey.

Authors:  G Gerasimov; O Judenitch; E Zdanova; N Jurieva; I Korostishevskaja; K Mushinskaja; I Dedov; D Glinoer
Journal:  J Endocrinol Invest       Date:  1992 Jul-Aug       Impact factor: 4.256

Review 3.  Endemic goiter and endemic thyroid disorders.

Authors:  E Gaitan; N C Nelson; G V Poole
Journal:  World J Surg       Date:  1991 Mar-Apr       Impact factor: 3.352

Review 4.  Diagnosis and management of Graves disease: a global overview.

Authors:  Luigi Bartalena
Journal:  Nat Rev Endocrinol       Date:  2013-10-15       Impact factor: 43.330

5.  Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.

Authors:  K Sugino; T Mimura; O Ozaki; H Iwasaki; N Wada; A Matsumoto; K Ito
Journal:  J Endocrinol Invest       Date:  1995-06       Impact factor: 4.256

6.  Outcomes After Urgent Thyroidectomy Following Rapid Control of Thyrotoxicosis in Graves' Disease are Similar to Those After Elective Surgery in Well-Controlled Disease.

Authors:  Adibah Ali; Miguel Debono; Sabapathy P Balasubramanian
Journal:  World J Surg       Date:  2019-12       Impact factor: 3.352

7.  Role of colestipol in the treatment of hyperthyroidism.

Authors:  P Hagag; H Nissenbaum; M Weiss
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256

8.  Antithyroid drug and Graves' hyperthyroidism. Significance of treatment duration and TRAb determination on lasting remission.

Authors:  R V García-Mayor; C Páramo; R Luna Cano; L F Pérez Mendez; J C Galofré; A Andrade
Journal:  J Endocrinol Invest       Date:  1992-12       Impact factor: 4.256

9.  Ultrasonography thyroid volume estimation in hyperthyroid patients treated with individual radioiodine dose.

Authors:  F Massaro; L Vera; M Schiavo; C Lagasio; M Caputo; M Bagnasco; F Minuto; M Giusti
Journal:  J Endocrinol Invest       Date:  2007-04       Impact factor: 4.256

Review 10.  Ablative or non-ablative therapy for Graves' hyperthyroidism in patients with ophthalmopathy?

Authors:  A P Weetman; B J Harrison
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.